Cargando…
Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights
BACKGROUND: Medulloblastoma is the most common malignant brain tumor in children, currently treated uniformly based on histopathology and clinico-radiological risk stratification leading to unpredictable relapses and therapeutic failures. Identification of molecular subgroups have thrown light on th...
Autores principales: | Khatua, Soumen, Song, Anne, Sridhar, Divyaswathi Citla, Mack, Stephen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120114/ https://www.ncbi.nlm.nih.gov/pubmed/29189165 http://dx.doi.org/10.2174/1570159X15666171129111324 |
Ejemplares similares
-
Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022) -
Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
por: Agarwal, Nikki, et al.
Publicado: (2021) -
Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment
por: Rechberger, Julian S., et al.
Publicado: (2023) -
Rethinking medulloblastoma from a targeted therapeutics perspective
por: Hashimoto, Yuuri, et al.
Publicado: (2018) -
MDB-35. RECURRENT MEDULLOBLASTOMA A RARE COMPLETE RESPONSE IN EXTRA NEURAL DISEASE
por: Schwartz, Jonathan, et al.
Publicado: (2023)